Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc., 64013-64014 [2013-25062]
Download as PDF
<![CDATA[
64013
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
Dated: October 22, 2013.
Jerri Murray,
Department Clearance Officer, PRA, U.S.
Department of Justice.
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
[FR Doc. 2013–25161 Filed 10–24–13; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
[OMB Number 1121—NEW]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Geospatial
Capabilities Survey
emcdonald on DSK67QTVN1PROD with NOTICES
ACTION:
Overview of This Information
Collection
30-day Notice.
The Department of Justice (DOJ),
National Institute of Justice (NIJ), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 78, Number 156, page
49288, on August 13, 2013, allowing for
a 60-day comment period.
The purpose of this notice is to allow
an additional 30 days for public
comment until November 25, 2013 This
process is conducted in accordance with
5 CFR 1320.10.
Written comments concerning this
information collection should be sent to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attn: DOJ Desk Officer. The best
way to ensure your comments are
received is to email them to oira_
submission@omb.eop.gov or fax them to
202–395–7285. All comments should
reference the 8 digit OMB number for
the collection or the title of the
collection. If you have questions
concerning the collection, please call
Joel Hunt at 202–616–8111.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Mar<15>2010
17:55 Oct 24, 2013
Jkt 232001
(1) Type of Information Collection:
Establishment survey and initial
approval of collection.
(2) Title of Form/Collection:
Geospatial Capabilities Survey.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: None.
National Institute of Justice, Office of
Justice Programs, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Law enforcement
agencies with 100 or more sworn
officers. These law enforcement
agencies include police departments,
sheriff agencies, and state police
agencies. This collection is the only
effort that provides an ability to
determine, in detail, the geospatial
tools, techniques, and practices in use
currently at large law enforcement
agencies. The results of the survey will
help NIJ determine how best it can meet
the needs and enhance the effectiveness
of geospatial capabilities among crime
analysts in large police departments
through future technology development
grants. There is little data on the
specific geospatial capabilities of law
enforcement agencies and hence little
data on which to base technology grant
decisions to enhance crime analysis
tools and techniques. This survey will
update the information gathered in the
Use of Computerized Crime Mapping
Survey conducted by NIJ in 1997, the
last survey on use of computerized
crime analysis tools by NIJ and establish
the basis for future technology
development funding. This collection
will also enable Federal, State, and local
law enforcement agencies; legislators;
researchers; and government agencies to
understand the depth, range, and scope
of geospatial capabilities currently in
use at large law enforcement agencies
and develop approaches to extend and
enhance these capabilities towards
improving policing strategies and public
safety through crime solving and
prevention.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The survey will invite all of
the 907 law enforcement agencies with
100 or more sworn officers to participate
in the survey. The law enforcement
agencies will select the personnel most
fitting to their organization to provide
the responses. The survey is estimated
to take one hour to complete.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 907
total burden hours associated with this
collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room 3W–
1407–B, Washington, DC 20530.
Dated: October 22, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2013–25160 Filed 10–24–13; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Cambrex
Charles City, Inc.
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on July 24, 2013, Cambrex Charles
City, Inc., 1205 11th Street, Charles City,
Iowa 50616–3466, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Drug
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
II
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
E:\FR\FM\25OCN1.SGM
25OCN1
64014
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
such basic classes of controlled
substances listed in schedules I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act [21 U.S.C.
952(a)(2)(B)] may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 25, 2013.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: September 27, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–25062 Filed 10–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
emcdonald on DSK67QTVN1PROD with NOTICES
Importer of Controlled Substances,
Notice of Application, Wildlife
Laboratories, Inc.
Schedule
VerDate Mar<15>2010
17:55 Oct 24, 2013
I
Jkt 232001
Etorphine HCl (9059) ...................
II
The company plans to import the
listed controlled substances for sale to
its customers.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act [21 U.S.C.
952(a)(2)(B)] may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 25, 2013.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
[FR Doc. 2013–25077 Filed 10–24–13; 8:45 am]
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on August 23, 2013, Wildlife
Laboratories, Inc., 1230 Wash Street,
Suite D, Windsor, Colorado 80550,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the following basic classes of controlled
substances:
Etorphine (except HCl) (9056) .....
Schedule
Dated: October 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
Drug
Drug
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Penick
Corporation
This is notice that on February 28,
2013, Penick Corporation, 33 Industrial
Park Road, Pennsville, New Jersey
08070, made application by renewal to
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
the Drug Enforcement Administration
(DEA) for registration as an importer of
the following basic classes of controlled
substances:
Drug
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substance
intermediates for sale to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
applicants for registration to import a
basic class of any controlled substance
in schedules I or II are, and will
continue to be, required to demonstrate
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration, that the
requirements for such registration
pursuant to 21 U.S.C. 958(a); 21 U.S.C.
823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: October 17, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–25064 Filed 10–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; United States
Pharmacopeial Convention
Pursuant to Title 21 Code of Federal
Regulations 1301.34 (a), this is notice
that on July 31, 2013, United States
Pharmacopeial Convention, 12601
Twinbrook Parkway, Rockville,
Maryland 20852, made application to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to import
reference standards for sale to
researchers and analytical labs.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
listed in schedules I and II, which fall
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 64013-64014]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25062]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application; Cambrex
Charles City, Inc.
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on July 24, 2013, Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616-3466, made application by renewal to
the Drug Enforcement Administration (DEA) for registration as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
internal use, and to manufacture bulk intermediates for sale to its
customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture
[[Page 64014]]
such basic classes of controlled substances listed in schedules I or
II, which fall under the authority of section 1002(a)(2)(B) of the Act
[21 U.S.C. 952(a)(2)(B)] may, in the circumstances set forth in 21
U.S.C. 958(i), file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43 and in
such form as prescribed by 21 CFR 1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than November 25, 2013.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745, all applicants for
registration to import a basic class of any controlled substance in
schedules I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: September 27, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-25062 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P
